A tumor-pH-responsive phthalocyanine as activatable type I photosensitizer for improved photodynamic immunotherapy DOI
Ling Zhang,

Rongbin Que,

Ke Tang

et al.

Journal of Photochemistry and Photobiology B Biology, Journal Year: 2024, Volume and Issue: 261, P. 113067 - 113067

Published: Nov. 19, 2024

Language: Английский

Multifunctional metal-organic frameworks with photothermal-triggered nitric oxide release for gas/photothermal synergistic cancer therapy DOI
Xingyu Luo, Tian Zhao,

Shuheng Qin

et al.

Journal of Colloid and Interface Science, Journal Year: 2025, Volume and Issue: 684, P. 47 - 59

Published: Jan. 4, 2025

Language: Английский

Citations

2

Mitochondria-Targeting Type-I Photodynamic Therapy Based on Phenothiazine for Realizing Enhanced Immunogenic Cancer Cell Death via Mitochondrial Oxidative Stress DOI Creative Commons

Zeyu Duan,

Lie Li,

Qiyu Zhan

et al.

International Journal of Nanomedicine, Journal Year: 2025, Volume and Issue: Volume 20, P. 125 - 139

Published: Jan. 1, 2025

Photo-immunotherapy faces challenges from poor immunogenicity and low response rate due to hypoxic microenvironment. This study presents Rh-PTZ, a small organic molecule with D-π-A structure, that simultaneously amplifies mitochondria-targeted type-I PDT-dependent immune stimulation for the treatment of cancer. The hydrophobic Rh-PTZ was encapsulated into F127 prepare nanoparticles (Rh-PTZ NPs). ROS generation ability, mitochondrial targeting capacity, ICD triggering effect mediated by NPs under LED light irradiation were investigated. Based on 4T1 subcutaneous tumor model, in vivo biological safety assessment, NIR fluorescent imaging, efficacy PDT assessed. could efficiently accumulate site induce O2 •- •OH burst situ irradiation, thereby causing severe dysfunction. can amplify stress-caused immunogenic cell death (ICD) stimulate response, promote maturation sufficient dendritic cells (DCs), enhance infiltration cells, alleviate immunosuppressive mitochondria-targeting holds promise photo-immunotherapy hypoxia overcoming limitations traditional immunotherapy.

Language: Английский

Citations

1

Autophagy inhibition mediated via an injectable and NO-releasing hydrogel for amplifying the antitumor efficacy of mild magnetic hyperthermia DOI Creative Commons

Yaoben Wang,

Xiaobin Chen, Zhiyong Chen

et al.

Bioactive Materials, Journal Year: 2024, Volume and Issue: 39, P. 336 - 353

Published: May 25, 2024

While mild hyperthermia holds great potential in the treatment of solid tumors, thermal stress-triggered self-repairing autophagy significantly compromises its efficacy. To circumvent this obstacle, an injectable hydrogel (NO-Gel) composed thermosensitive poly(ethylene glycol)-polypeptide copolymers modified with abundant NO donors on their side chains is developed. Meanwhile, ferrimagnetic Zn

Language: Английский

Citations

8

GSH-Responsive Liposomes with Heat Shock Protein Regulatory Ability for Efficient Photodynamic/Photothermal Combined Therapy of Tumors DOI
Hairui Deng, Xianan Li,

Lingfeng Pan

et al.

ACS Applied Materials & Interfaces, Journal Year: 2024, Volume and Issue: 16(20), P. 25788 - 25798

Published: May 8, 2024

Phototherapy, represented by photodynamic therapy (PDT) and photothermal (PTT), has great potential in tumor treatment. However, the presence of antioxidant glutathione (GSH) heat shock proteins (HSPs) expression caused high temperature can weaken effects PDT PTT. Here, a multifunctional nanocomplex BT&GA@CL is constructed to realize enhanced synergistic PDT/PTT. Cinnamaldehyde liposomes (CLs) formed cinnamaldehyde dimer self-assembly were loaded with gambogic acid (GA) an aggregation-induced emission molecule BT obtain BT&GA@CL. As drug carrier, CL consume release drugs responsively. The released aggregates simultaneously act as both agent photosensitizer achieve PTT under 660 nm laser irradiation. Specifically, GA HSP90 inhibitor attenuate PTT-induced protein expression, thereby weakening tolerance cells temperatures enhancing Such modulates content GSH cells, thus PTT, ultimately achieving goal efficient combined suppression.

Language: Английский

Citations

6

A Photoactivated Self‐Assembled Nanoreactor for Inducing Cascade‐Amplified Oxidative Stress toward Type I Photodynamic Therapy in Hypoxic Tumors DOI

Xuan Luo,

Qishu Jiao,

Shicheng Pei

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 5, 2024

Abstract Type I photodynamic therapy (PDT) generates reactive oxygen species (ROS) through oxygen‐independent photoreactions, making it a promising method for treating hypoxic tumors. However, the superoxide anion (O 2 ∙ – ) generated usually exhibits low oxidation capacity, restricting antitumor efficacy of PDT in clinical practice. Herein, photoactivated self‐assembled nanoreactor ( 1 ‐NBS@CeO is designed integration type and cerium oxide (CeO nanozymes inducing cascade‐amplified oxidative stress The constructed though co‐assembly an amphiphilic peptide ‐NBS) CeO , giving well‐dispersed spherical nanoparticles with enhanced dismutase (SOD)‐like peroxidase (POD)‐like activities. Following light irradiation, undergoes photoreactions to O which further catalyzed by nanoreactors, ultimately forming hypertoxic hydroxyl radical (∙OH) reactions. treatment using results elevation intracellular ROS depletion GSH content A375 cells, thereby mitochondrial dysfunction triggering apoptosis ferroptosis tumor cells. Importantly, intravenous administration alongside irradiation showcases enhances satisfactory biocompatibility vivo. Together, facilitates achieving efficacious PDT, holds great promise developing therapeutic modules towards

Language: Английский

Citations

4

Twin-Tail Tadpole-Shaped Ce6-Peptide Conjugate for Enhanced Photodynamic Cancer Therapy DOI
Mengmeng Jiang,

Shaowen Wu,

Hongxia Zhang

et al.

ACS Applied Bio Materials, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 5, 2025

Despite its therapeutic potential, photodynamic therapy faces several key limitations in clinical applications, including poor drug delivery and insufficient tumor selectivity. We engineered RFYFYR-Ce6-RFYFYR (R-Ce6-R), a twin-tail peptide–photosensitizer conjugate that self-assembles into nanostructures for improved cancer treatment. By incorporating arginine-rich peptide sequences, this design not only enhances cellular internalization but also promotes peroxynitrite (ONOO–) formation, amplifying the effect. Our studies revealed R-Ce6-R achieves 33-fold higher potency than unmodified Ce6, with an IC50 of 0.18 μM. The demonstrated selective accumulation tissue, robust ROS generation, complete regression animal models while maintaining favorable safety profile. These results establish as innovative approach advancing

Language: Английский

Citations

0

Harnessing stimuli-responsive NO nanomaterials for advanced multi-disease therapy DOI
Junjie Zhang, Haiyang Guo, Longguang Tang

et al.

Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 533, P. 216540 - 216540

Published: Feb. 27, 2025

Language: Английский

Citations

0

Multifunctional nanoparticle-mediated targeting of metabolic reprogramming and DNA damage response pathways to treat drug-resistant triple-negative breast cancer DOI
Sifeng Zhu, Chao Sun,

Zimin Cai

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: 381, P. 113601 - 113601

Published: March 5, 2025

Language: Английский

Citations

0

Evolution of nMOFs in photodynamic therapy: from porphyrins to chlorins and bacteriochlorins for better efficacy DOI Creative Commons
Yutao Zou, Jiayi Chen, Yingli Qu

et al.

Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16

Published: March 18, 2025

Photodynamic therapy (PDT) has gained significant attention due to its non-invasive nature, low cost, and ease of operation. Nanoscale metal-organic frameworks (nMOFs) incorporating porphyrins, chlorins, bacteriochlorins have emerged as one the most prominent photoactive materials for tumor PDT. These nMOFs could enhance water solubility, stability loading efficiency photosensitizers (PSs). Their highly ordered porous structure facilitates O2 diffusion enhances generation 1O2 from hydrophobic bacteriochlorins, thereby improving their efficacy phototherapy. This review provides insights into PDT effects derived bacteriochlorins. It overviews design strategies, types reactive oxygen species (ROS), ROS efficiency, unique biological processes involved in inhibiting cell proliferation, focusing on mechanism by which molecular leads enhanced photochemical properties. Finally, highlights new possibilities offered bacteriochlorins-based PDT, emphasizing how optimized can further improve bioapplication porphyrin derivatives represented PSs. With ongoing research technological advancements, we anticipate that this will garner increased scientific researchers toward porphyrin-based nMOFs, elevating potential a approach treatment malignant tumors.

Language: Английский

Citations

0

The Orthogonal α‐meso‐Linked bisBODIPY Photosensitizers Demonstrate Effective Two‐Photon Fluorescence Imaging and Photodynamic Therapy DOI

Luying Guo,

Xing Guo,

Huiquan Zuo

et al.

ChemPhotoChem, Journal Year: 2024, Volume and Issue: 8(9)

Published: April 30, 2024

Abstract Hypoxic tumor microenvironments pose significant challenges to the clinical translation of cancer photodynamic therapy (PDT). While heavy atom‐free Type‐I boron dipyrromethenes (BODIPYs) photosensitizers can alleviate this challenge by reducing oxygen dependency, but they remain scarce. Herein, heavy‐atom‐free α,meso ‐linked bisBODIPYs were designed and synthesized. These exhibit remarkable red‐shifted emission (λemmax ~670 nm), large Stokes shifts (~4480 cm −1 ) are capable producing both superoxide anion (O 2 ⋅ − singlet ( 1 O in solution cells. Additionally, offer a wide PDT treatment window, ranging from 0.26 83.5 μM. Furthermore, these also demonstrate superior two‐photon fluorescence, promising for surgical navigation integrating diagnosis with treatment.

Language: Английский

Citations

3